daunorubicin has been researched along with Acute Confusional Senile Dementia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bulic, B; Mandelkow, E; Pickhardt, M | 1 |
Enokita, M; Hashimoto, T; Hori, Y; Iwatsubo, T; Kato, M; Kinoshita, H; Toyo'oka, T | 1 |
George, AR; Howlett, DR; Markwell, RE; Owen, DE; Ward, RV | 1 |
1 review(s) available for daunorubicin and Acute Confusional Senile Dementia
Article | Year |
---|---|
Progress and developments in tau aggregation inhibitors for Alzheimer disease.
Topics: Alzheimer Disease; Animals; Clinical Trials as Topic; Humans; Hydrogen Bonding; Models, Molecular; Protein Binding; Protein Conformation; Structure-Activity Relationship; tau Proteins | 2013 |
2 other study(ies) available for daunorubicin and Acute Confusional Senile Dementia
Article | Year |
---|---|
Analytical method for beta-amyloid fibrils using CE-laser induced fluorescence and its application to screening for inhibitors of beta-amyloid protein aggregation.
Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Peptides; Benzothiazoles; Daunorubicin; Fluorescence; Fluorescent Dyes; Humans; Indoles; Lasers; Mass Screening; Melatonin; Molecular Sequence Data; Propionates; Sensitivity and Specificity; Thiazoles; Time Factors | 2007 |
Common structural features determine the effectiveness of carvedilol, daunomycin and rolitetracycline as inhibitors of Alzheimer beta-amyloid fibril formation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Carbazoles; Carvedilol; Cell Survival; Daunorubicin; Humans; Inhibitory Concentration 50; Microscopy, Electron; Models, Chemical; Molecular Structure; Neurons; Polymers; Propanolamines; Protein Binding; Rolitetracycline; Structure-Activity Relationship; Tetrazolium Salts; Thermodynamics; Thiazoles; Tumor Cells, Cultured | 1999 |